scholarly journals Serum Levels of Adipokine Retinol-Binding Protein-4 in Relation to Renal Function

Diabetes Care ◽  
2007 ◽  
Vol 30 (10) ◽  
pp. 2588-2592 ◽  
Author(s):  
M. Ziegelmeier ◽  
A. Bachmann ◽  
J. Seeger ◽  
U. Lossner ◽  
J. Kratzsch ◽  
...  
Keyword(s):  
Renal Function ◽  
Binding Protein ◽  
Serum Levels ◽  
Retinol Binding Protein ◽  
Retinol Binding Protein 4

scholarly journals Serum Levels of Adipokine Retinol-Binding Protein-4 in Relation to Renal Function: Response to Papavasileiou et al.

Diabetes Care ◽  
2008 ◽  
Vol 31 (4) ◽  
pp. e24-e24
Author(s):  
M. Ziegelmeier ◽  
A. Bachmann ◽  
J. Seeger ◽  
U. Lossner ◽  
M. Bluher ◽  
...  
Keyword(s):  
Renal Function ◽  
Binding Protein ◽  
Serum Levels ◽  
Retinol Binding Protein ◽  
Retinol Binding Protein 4

scholarly journals Serum Levels of Adipokine Retinol-Binding Protein-4 in Relation to Renal Function: Response to Ziegelmeier et al.

Diabetes Care ◽  
2008 ◽  
Vol 31 (4) ◽  
pp. e23-e23 ◽  
Author(s):  
V. Papavasileiou ◽  
V. Liakopoulos ◽  
G. K. Sakkas ◽  
G. M. Hadjigeorgiou ◽  
G. Koukoulis ◽  
...  
Keyword(s):  
Renal Function ◽  
Binding Protein ◽  
Serum Levels ◽  
Retinol Binding Protein ◽  
Retinol Binding Protein 4

scholarly journals Serum levels of retinol-binding protein 4 and risk of colon adenoma

2015 ◽  
Vol 22 (2) ◽  
pp. L1-L4 ◽  
Author(s):  
Matthew V Abola ◽  
Cheryl L Thompson ◽  
Zhengyi Chen ◽  
Amitabh Chak ◽  
Nathan A Berger ◽  
...  
Keyword(s):  
Binding Protein ◽  
Serum Levels ◽  
Retinol Binding Protein ◽  
Colon Adenoma ◽  
Retinol Binding Protein 4

scholarly journals Serum levels of retinol-binding protein 4 and the risk of non-small cell lung cancer

Medicine ◽  
2020 ◽  
Vol 99 (31) ◽  
pp. e21254
Author(s):  
Xiaoping Hu ◽  
Wenjun Huang ◽  
Feng Wang ◽  
Yifei Dai ◽  
Xiaocong Hu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Binding Protein ◽  
Serum Levels ◽  
Small Cell ◽  
Retinol Binding Protein ◽  
Small Cell Lung ◽  
Retinol Binding Protein 4

scholarly journals Serum levels of retinol binding protein 4 in women with different levels of adiposity and glucose tolerance

2014 ◽  
Vol 58 (7) ◽  
pp. 709-714 ◽  
Author(s):  
Eleonora Beltrame Comucci ◽  
Ana Carolina Junqueira Vasques ◽  
Bruno Geloneze ◽  
Antonio Ramos Calixto ◽  
José Carlos Pareja ◽  
...  
Keyword(s):  
Glucose Tolerance ◽  
Glycated Hemoglobin ◽  
Binding Protein ◽  
Serum Levels ◽  
Normal Glucose Tolerance ◽  
Cross Sectional Study ◽  
Retinol Binding Protein ◽  
Cross Sectional ◽  
Retinol Binding Protein 4 ◽  
Wide Range

Objective Retinol-binding protein 4 (RBP4) is an adipokine responsible for vitamin A (retinol) transportation. Studies associated RBP4 increased levels with severity of type 2 diabetes mellitus (T2DM) and insulin resistance (IR). The study aimed to quantify RBP4 serum standards in women with a wide range of body mass index (BMI) and glucose tolerance level. Subjects and methods: Cross-sectional study was performed with 139 women divided into three groups: Group 1 (lean-control, n = 45) and Group 2 (obese, n = 53) with normal glucose tolerance and group 3 (obese with T2DM, n = 41), called G1, G2 and G3. Were assessed clinical, biochemical, anthropometric and body composition parameters. Results According to data analysis, we obtained in G1 higher RBP4 levels (104.8 ± 76.8 ng/mL) when compared to G2 (87.9 ± 38 ng/mL) and G3 (72.2 ± 15.6 ng/mL) levels. Also, were found: in G1 positive correlations of RBP4 with BMI (r = 0.253), glycated hemoglobin (r = 0.378) and fasting insulin (r = 0.336); in G2 with glycated hemoglobin (r = 0.489); in G3 with glycated hemoglobin (r = 0.330), fasting glucose (r = 0.463), HOMA-IR (r = 0.481). Conclusions Although RBP4 have shown lower levels in diabetic and obese, a strong correlation with HOMA-IR index highlights that, in our study, there is growing IR when there is an increasing in RBP4 levels.

scholarly journals Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease

2014 ◽  
Vol 13 (1) ◽  
Author(s):  
Vaia Lambadiari ◽  
Nikolaos PE Kadoglou ◽  
Vassilios Stasinos ◽  
Eirini Maratou ◽  
Aias Antoniadis ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Binding Protein ◽  
Serum Levels ◽  
Retinol Binding Protein ◽  
Retinol Binding Protein 4 ◽  
Artery Disease

Retinol-Binding Protein 4 Levels Are Associated with Measures of Liver and Renal Function and Oxidant/Antioxidant Status in Obese Children

2013 ◽  
Vol 163 (2) ◽  
pp. 593-595 ◽  
Author(s):  
Pilar Codoñer-Franch ◽  
Antonio Mora-Herranz ◽  
Raquel Simó-Jordá ◽  
Clara Pérez-Rambla ◽  
Laura Boix-García ◽  
...  
Keyword(s):  
Renal Function ◽  
Antioxidant Status ◽  
Binding Protein ◽  
Retinol Binding Protein ◽  
Obese Children ◽  
Retinol Binding Protein 4

scholarly journals Serum retinol-binding protein 4 levels in polycystic ovary syndrome

2019 ◽  
Vol 8 (6) ◽  
pp. 709-717
Author(s):  
Shilpa Lingaiah ◽  
Laure Morin-Papunen ◽  
Terhi Piltonen ◽  
Inger Sundström-Poromaa ◽  
Elisabet Stener-Victorin ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Binding Protein ◽  
Serum Levels ◽  
Retinol Binding Protein ◽  
Enzyme Linked Immunosorbent Assay ◽  
Serum Retinol ◽  
Ovary Syndrome ◽  
Retinol Binding Protein 4

Objective Serum levels of retinol-binding protein 4 (RBP4), an adipokine thought to affect systemic insulin sensitivity, were compared between women with polycystic ovary syndrome (PCOS) and non-PCOS controls to evaluate the association of RBP4 with clinical, hormonal and metabolic parameters of PCOS. Subjects and methods Serum RBP4 levels were analysed in 278 women with PCOS (age range 18–57 years) and 191 non-PCOS controls (age 20–53 years) by enzyme-linked immunosorbent assay. Results Serum levels of RBP4 were increased in women with PCOS compared with control women in the whole population (45.1 ± 24.0 (s.d.) vs 33.5 ± 18.3 mg/L, P < 0.001). Age-stratified analysis showed that serum RBP4 levels were increased in women with PCOS aged ≤30 years compared with controls (47.7 ± 23.5 vs 27.1 ± 10.4 mg/L, P < 0.001), whereas no significant differences were seen in the other age groups. No significant correlations of RBP4 were seen with either steroids or indices of insulin resistance. Conclusions Although serum RBP4 levels were increased in younger women with PCOS compared with age-matched non-PCOS controls, RBP4 does not seem to be a good marker of insulin resistance or other metabolic derangements in women with PCOS.

Sign in / Sign up

Export Citation Format

Share Document